U.S. Sucralfate Market, By Formulation, By Indication, By Distribution Channel, By State

PUBLISHED: February 2, 2026

PAGES: 152 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

U.S. Sucralfate Market is estimated to be valued at USD 100 Mn in 2026 and is expected to reach USD 125 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 100 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	3.20%	2033 Value Projection:	USD 125 Mn

Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly. Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease.

Market Dynamics

Increasing clinical trials for exploring different uses of sucralfate for different indications is a major factor driving U.S. sucralfate market growth. For instance, according to the study published by the National Center of Biotechnology Information, in 2016, a clinical trial conducted on Radiation Proctitis patients receiving sucralfate treatment showed 92.3% positive results in 16 weeks.

Furthermore, monitoring of drugs including sucralfate in the U.S. by the government authorities for avoiding fatal conditions in the population is expected to drive the market growth. For instance, in 2017, the U.S. FDA updated name of 'Carafate suspension' to 'Carafate oral suspension' to avoid fatal complications with mistakenly intravenous administration of the drug.

Key features of the study

This report provides in-depth analysis of the U.S. sucralfate market and provides market size (USD million) and compound annual growth rate (CAGR %) for the forecast period (2018-2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the U.S. sucralfate market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The U.S. sucralfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. sucralfate market

Market Segmentation

Formulation Insights (Revenue, USD Mn, 2026 - 2033)
- Tablet
- Liquid Suspension
Indication Insights (Revenue, USD Mn, 2026 - 2033)
- Gastric Ulcers
- Duodenal Ulcers
- Gastro Esophageal Reflux Disease (GERD)
- Others
Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
State Insights (Revenue, USD Mn, 2026 - 2033)
- Illinois
- Texas
- New York
- California
- Others
Key Players Insights
- Teva Pharmaceutical Industries Ltd.
- Allergan plc
- Vertice Pharma LLC
- Pharmaceutical Associates Inc. (PAI)

Product Code: CMI2975

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- U.S. Sucralfate Market, By Formulation
- U.S. Sucralfate Market, By Indication
- U.S. Sucralfate Market, By Distribution Channel
- U.S. Sucralfate Market, By State

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend

4. U.S. Sucralfate Market, By Formulation, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Liquid Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. U.S. Sucralfate Market, By Indication, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Gastric Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Duodenal Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Gastro Esophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. U.S. Sucralfate Market, By Distribution Channel, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. U.S. Sucralfate Market, By State, 2026 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
- Regional Trends
Illinois
- Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn)
Texas
- Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn)
New York
- Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn)
California
- Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn)
Others
- Introduction
- Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn)

8. Competitive Landscape

Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Allergan plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vertice Pharma LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pharmaceutical Associates Inc. (PAI)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies